LXRX Earnings Lexicon Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 0.00 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.14 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.10 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.06 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.07 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.63 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -0.54 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.37 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.20 | 2025-05-14 | 10-Q |
| FY 2025 | 2023-12-31 | -0.80 | 2026-03-05 | 10-K |
| Q3 2024 | 2023-09-30 | -0.60 | 2024-11-13 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.39 | 2024-08-02 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.17 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -0.62 | 2025-03-07 | 10-K |
| Q3 2023 | 2022-09-30 | -0.45 | 2023-11-08 | 10-Q |
| FY 2023 | 2021-12-31 | -0.60 | 2024-03-25 | 10-K |
| Q3 2021 | 2021-09-30 | -0.43 | 2021-11-09 | 10-Q |
| FY 2019 | 2020-12-31 | -0.53 | 2022-03-10 | 10-K |
| Q3 2021 | 2020-09-30 | -0.50 | 2021-11-09 | 10-Q |
| FY 2019 | 2019-12-31 | 1.16 | 2022-03-10 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.